Global ASEAN Point of Care Diagnostics Market Size study & Forecast, by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), by Technology (Lateral Flow Assays, Biochemistry, MDx), by End User (Home Care, Hospitals), and Regional Forecasts 2025-2035
The Global ASEAN Point of Care Diagnostics Market is valued at approximately USD 1.03 billion in 2024 and is expected to register a promising compound annual growth rate (CAGR) of 4.70% over the forecast period from 2025 to 2035. Point of Care (PoC) Diagnostics has emerged as a pivotal enabler of decentralized healthcare delivery—empowering clinicians and patients alike with rapid diagnostic insights, often at the bedside or in near-patient settings. As ASEAN nations experience a surge in both urbanization and rural healthcare needs, PoC technologies are uniquely positioned to bridge gaps in access, responsiveness, and affordability. Whether addressing infectious diseases or chronic metabolic conditions, the real-time data rendered by these tools is reshaping clinical pathways and policy direction across Southeast Asia.
What’s fueling this momentum is the increasing burden of both communicable and non-communicable diseases, along with a parallel surge in awareness regarding early diagnosis and preventive care. The ASEAN region is witnessing a sharp rise in the demand for accessible, compact, and user-friendly diagnostic devices that can function even in low-resource environments. This, combined with advancements in molecular diagnostics and the integration of digital health infrastructure, is enabling a new generation of smart, portable PoC devices. Governments across ASEAN are also recognizing the utility of these solutions in pandemic preparedness, primary care reinforcement, and health equity expansion—creating fertile ground for innovation and investment.
From a regional perspective, Southeast Asia is undergoing a healthcare transformation. Countries like Singapore and Malaysia are investing heavily in precision diagnostics and digital health ecosystems, while Indonesia, Vietnam, and the Philippines are scaling their rural and public health infrastructures. These nations are leveraging PoC diagnostics to offset the limitations of centralized laboratory systems—particularly in remote or underserved regions. Meanwhile, Thailand’s thriving medical tourism and diagnostic manufacturing sectors have further enhanced regional production and cross-border technology transfers. The ASEAN bloc’s regulatory harmonization efforts and incentives for healthcare technology startups are also expected to accelerate cross-market adoption during the forecast period.
Major market player included in this report are:
By Product:
North America
What’s fueling this momentum is the increasing burden of both communicable and non-communicable diseases, along with a parallel surge in awareness regarding early diagnosis and preventive care. The ASEAN region is witnessing a sharp rise in the demand for accessible, compact, and user-friendly diagnostic devices that can function even in low-resource environments. This, combined with advancements in molecular diagnostics and the integration of digital health infrastructure, is enabling a new generation of smart, portable PoC devices. Governments across ASEAN are also recognizing the utility of these solutions in pandemic preparedness, primary care reinforcement, and health equity expansion—creating fertile ground for innovation and investment.
From a regional perspective, Southeast Asia is undergoing a healthcare transformation. Countries like Singapore and Malaysia are investing heavily in precision diagnostics and digital health ecosystems, while Indonesia, Vietnam, and the Philippines are scaling their rural and public health infrastructures. These nations are leveraging PoC diagnostics to offset the limitations of centralized laboratory systems—particularly in remote or underserved regions. Meanwhile, Thailand’s thriving medical tourism and diagnostic manufacturing sectors have further enhanced regional production and cross-border technology transfers. The ASEAN bloc’s regulatory harmonization efforts and incentives for healthcare technology startups are also expected to accelerate cross-market adoption during the forecast period.
Major market player included in this report are:
- Abbott Laboratories
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- bioM?rieux SA
- Becton, Dickinson and Company
- Danaher Corporation
- QuidelOrtho Corporation
- EKF Diagnostics Holdings plc
- Nova Biomedical Corporation
- Instrumentation Laboratory (Werfen)
- Trinity Biotech
- Sekisui Diagnostics LLC
- PTS Diagnostics
- Bio-Rad Laboratories, Inc.
- Historical Data – 2023, 2024
- Base Year for Estimation – 2024
- Forecast period – 2025-2035
- Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
By Product:
- Infectious Disease
- TB
- Hepatitis
- STDs
- HAIs
- Glucose
- Cardiometabolic
- Pregnancy
- Coagulation
- Lateral Flow Assays
- Biochemistry
- Molecular Diagnostics (MDx)
- Home Care
- Hospitals
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Market Estimates & Forecast for 10 years from 2025 to 2035.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
CHAPTER 1. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET REPORT SCOPE & METHODOLOGY
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
CHAPTER 2. EXECUTIVE SUMMARY
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
CHAPTER 3. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET FORCES ANALYSIS
3.1. Market Forces Shaping The Global ASEAN Point of Care Diagnostics Market (2024-2035)
3.2. Drivers
3.2.1. Rising burden of communicable and non-communicable diseases
3.2.2. Growing awareness regarding early diagnosis and preventive care
3.2.3. Government initiatives and investments in primary healthcare
3.3. Restraints
3.3.1. Regulatory complexities across ASEAN countries
3.3.2. Limited infrastructure in remote regions
3.4. Opportunities
3.4.1. Integration of digital health with PoC diagnostics
3.4.2. Rising investment in healthcare innovation across Southeast Asia
CHAPTER 4. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS INDUSTRY ANALYSIS
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY PRODUCT 2025-2035
5.1. Infectious Disease
5.1.1. TB
5.1.2. Hepatitis
5.1.3. STDs
5.1.4. HAIs
5.2. Glucose
5.3. Cardiometabolic
5.4. Pregnancy
5.5. Coagulation
CHAPTER 6. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY TECHNOLOGY 2025–2035
6.1. Lateral Flow Assays
6.2. Biochemistry
6.3. Molecular Diagnostics (MDx)
CHAPTER 7. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY END USER 2025–2035
7.1. Home Care
7.2. Hospitals
CHAPTER 8. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY REGION 2025–2035
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.2. Europe
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Spain
8.2.5. Italy
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.5. Middle East & Africa
8.5.1. UAE
8.5.2. Saudi Arabia
8.5.3. South Africa
8.5.4. Rest of Middle East & Africa
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Abbott Laboratories
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Financial Performance (Subject to Data Availability)
9.2.5. Product/Services Port
9.2.6. Recent Development
9.2.7. Market Strategies
9.2.8. SWOT Analysis
9.3. Siemens Healthineers
9.4. F. Hoffmann-La Roche Ltd
9.5. Thermo Fisher Scientific Inc.
9.6. bioM?rieux SA
9.7. Becton, Dickinson and Company
9.8. Danaher Corporation
9.9. QuidelOrtho Corporation
9.10. EKF Diagnostics Holdings plc
9.11. Nova Biomedical Corporation
9.12. Instrumentation Laboratory (Werfen)
9.13. Trinity Biotech
9.14. Sekisui Diagnostics LLC
9.15. PTS Diagnostics
9.16. Bio-Rad Laboratories, Inc.
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
CHAPTER 2. EXECUTIVE SUMMARY
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
CHAPTER 3. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET FORCES ANALYSIS
3.1. Market Forces Shaping The Global ASEAN Point of Care Diagnostics Market (2024-2035)
3.2. Drivers
3.2.1. Rising burden of communicable and non-communicable diseases
3.2.2. Growing awareness regarding early diagnosis and preventive care
3.2.3. Government initiatives and investments in primary healthcare
3.3. Restraints
3.3.1. Regulatory complexities across ASEAN countries
3.3.2. Limited infrastructure in remote regions
3.4. Opportunities
3.4.1. Integration of digital health with PoC diagnostics
3.4.2. Rising investment in healthcare innovation across Southeast Asia
CHAPTER 4. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS INDUSTRY ANALYSIS
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY PRODUCT 2025-2035
5.1. Infectious Disease
5.1.1. TB
5.1.2. Hepatitis
5.1.3. STDs
5.1.4. HAIs
5.2. Glucose
5.3. Cardiometabolic
5.4. Pregnancy
5.5. Coagulation
CHAPTER 6. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY TECHNOLOGY 2025–2035
6.1. Lateral Flow Assays
6.2. Biochemistry
6.3. Molecular Diagnostics (MDx)
CHAPTER 7. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY END USER 2025–2035
7.1. Home Care
7.2. Hospitals
CHAPTER 8. GLOBAL ASEAN POINT OF CARE DIAGNOSTICS MARKET SIZE & FORECASTS BY REGION 2025–2035
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.2. Europe
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Spain
8.2.5. Italy
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.5. Middle East & Africa
8.5.1. UAE
8.5.2. Saudi Arabia
8.5.3. South Africa
8.5.4. Rest of Middle East & Africa
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Abbott Laboratories
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Financial Performance (Subject to Data Availability)
9.2.5. Product/Services Port
9.2.6. Recent Development
9.2.7. Market Strategies
9.2.8. SWOT Analysis
9.3. Siemens Healthineers
9.4. F. Hoffmann-La Roche Ltd
9.5. Thermo Fisher Scientific Inc.
9.6. bioM?rieux SA
9.7. Becton, Dickinson and Company
9.8. Danaher Corporation
9.9. QuidelOrtho Corporation
9.10. EKF Diagnostics Holdings plc
9.11. Nova Biomedical Corporation
9.12. Instrumentation Laboratory (Werfen)
9.13. Trinity Biotech
9.14. Sekisui Diagnostics LLC
9.15. PTS Diagnostics
9.16. Bio-Rad Laboratories, Inc.
LIST OF TABLES
Table 1. Global ASEAN Point of Care Diagnostics Market, Report Scope
Table 2. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By Region 2024–2035
Table 3. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By Product 2024–2035
Table 4. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By Technology 2024–2035
Table 5. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By End User 2024–2035
Table 6. U.S. ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 7. Canada ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 8. UK ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 9. Germany ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 10. France ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 11. Spain ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 12. Italy ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 13. Rest Of Europe ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 14. China ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 15. India ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 16. Japan ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 17. Australia ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 18. South Korea ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 19. Brazil ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 20. Mexico ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 21. UAE ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 22. Saudi Arabia ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 23. South Africa ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 1. Global ASEAN Point of Care Diagnostics Market, Report Scope
Table 2. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By Region 2024–2035
Table 3. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By Product 2024–2035
Table 4. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By Technology 2024–2035
Table 5. Global ASEAN Point of Care Diagnostics Market Estimates & Forecasts By End User 2024–2035
Table 6. U.S. ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 7. Canada ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 8. UK ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 9. Germany ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 10. France ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 11. Spain ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 12. Italy ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 13. Rest Of Europe ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 14. China ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 15. India ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 16. Japan ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 17. Australia ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 18. South Korea ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 19. Brazil ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 20. Mexico ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 21. UAE ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 22. Saudi Arabia ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
Table 23. South Africa ASEAN Point of Care Diagnostics Market Estimates & Forecasts, 2024–2035
LIST OF FIGURES
Fig 1. Global ASEAN Point of Care Diagnostics Market, Research Methodology
Fig 2. Global ASEAN Point of Care Diagnostics Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global ASEAN Point of Care Diagnostics Market, Key Trends 2025
Fig 5. Global ASEAN Point of Care Diagnostics Market, Growth Prospects 2024–2035
Fig 6. Global ASEAN Point of Care Diagnostics Market, Porter’s Five Forces Model
Fig 7. Global ASEAN Point of Care Diagnostics Market, PESTEL Analysis
Fig 8. Global ASEAN Point of Care Diagnostics Market, Value Chain Analysis
Fig 9. ASEAN Point of Care Diagnostics Market By Product, 2025 & 2035
Fig 10. ASEAN Point of Care Diagnostics Market By Technology, 2025 & 2035
Fig 11. ASEAN Point of Care Diagnostics Market By End User, 2025 & 2035
Fig 12. ASEAN Point of Care Diagnostics Market By Region, 2025 & 2035
Fig 13. Company Market Share Analysis (2025)
Fig 14. Top Investment Pockets by Region (2030)
Fig 15. Key Strategic Initiatives by Leading Players
Fig 1. Global ASEAN Point of Care Diagnostics Market, Research Methodology
Fig 2. Global ASEAN Point of Care Diagnostics Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global ASEAN Point of Care Diagnostics Market, Key Trends 2025
Fig 5. Global ASEAN Point of Care Diagnostics Market, Growth Prospects 2024–2035
Fig 6. Global ASEAN Point of Care Diagnostics Market, Porter’s Five Forces Model
Fig 7. Global ASEAN Point of Care Diagnostics Market, PESTEL Analysis
Fig 8. Global ASEAN Point of Care Diagnostics Market, Value Chain Analysis
Fig 9. ASEAN Point of Care Diagnostics Market By Product, 2025 & 2035
Fig 10. ASEAN Point of Care Diagnostics Market By Technology, 2025 & 2035
Fig 11. ASEAN Point of Care Diagnostics Market By End User, 2025 & 2035
Fig 12. ASEAN Point of Care Diagnostics Market By Region, 2025 & 2035
Fig 13. Company Market Share Analysis (2025)
Fig 14. Top Investment Pockets by Region (2030)
Fig 15. Key Strategic Initiatives by Leading Players
